Recent Updates
Recently added Catalysts

Smallpox vaccine, LISTER strain, from chick embryo cells

Phase 2

Smallpox | Monoclonal antibody | Infectious Disease |Sanofi|Last Updated: Feb 1, 2012

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindUNCONTROLLED
Total Trials1
Total Enrollment230

FDA Designations

No designations recorded

Clinical trial landscape

Smallpox vaccine, LISTER strain, from chick embryo cells · 1 trial · 2 indications

Phase 2 1
NCT00258947Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young AdultsSmallpox
COMPLETED230 Analytics
PHASE2COMPLETED
Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults
SmallpoxUnlock trial analytics

Study Design & Arms

AllocationRANDOMIZED
MaskingQUADRUPLE
ModelPARALLEL
PurposePREVENTION

Interventions

NameTypeDescription
Smallpox vaccine, LISTER strain, from chick embryo cellsBIOLOGICAL -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 25 Years
SexALL
Healthy VolunteersYes
Study Sites6

Inclusion Criteria: * Aged 18 to 25 years on the day of screening * Informed consent form signed * Able to attend all scheduled visits and to comply with all trial procedures * For a woman, inability to bear a child or negative serum pregnancy test performed at screening (Visit 01) * Subject entitl...

Countries:France
Unlock Eligibility Criteria